[1] World Health Organization. Global tuberculosis report 2016. 2016.
[2] WHO. WHO Global Tuberculosis Report 2014. 2014. doi:WHO/HTM/TB/2014.08.
[3] Kwamanga D, Chakaya J, Sitienei J, Kalisvaart N, L’Herminez R, Van Der Werf MJ. Tuberculosis transmission in Kenya: Results of the third National Tuberculin Survey. Int J Tuberc Lung Dis 2010.
[4] Enos M, Sitienei J, Ong’ang’o J, Mungai B, Kamene M, Wambugu J, et al. Kenya tuberculosis prevalence survey 2016: Challenges and opportunities of ending TB in Kenya. PLoS One 2018. doi:10.1371/journal.pone.0209098.
[5] Helb D, Jones M, Story E, Boehme C, Wallace E, Ho K, et al. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol 2010;48:229–37. doi:10.1128/JCM.01463-09.
[6] Haihe Wang, Chunyan Zhao FL. Rapid Identification of Mycobacterium Tuberculosis Complex By a Novel Hybridization. Brazilian J Microbiol 42 2011;42:964-972 964-972. doi:10.1590/S1517-838220110003000016.
[7] Centers for Disease Control and Prevention (CDC). CDC Grand Rounds: the TB/HIV syndemic. MMWR Morb Mortal Wkly Rep 2012;61:484–9. doi:mm6126a3 [pii].
[8] Woods GL. Mycobacterial susceptibility testing and reporting: When, how, and what to test. Clin Microbiol Newsl 2005. doi:10.1016/S0196-4399(05)80022-4.
[9] A.M. VT, P. B, J.A. C, A.C. T, J.D. J, D.M. B-M, et al. Optimizing prevention strategies and processes to reduce the impact of malaria on U.S. military forces. Am J Trop Med Hyg 2012.
[10] WHO. Global tuberculosis report 2016. 2016. doi:ISBN 978 92 4 156539 4.
[11] Meaza A, Kebede A, Yaregal Z, Dagne Z, Moga S, Yenew B, et al. Evaluation of genotype MTBDRplus VER 2.0 line probe assay for the detection of MDR-TB in smear positive and negative sputum samples. BMC Infect Dis 2017;17. doi:10.1186/s12879-017-2389-6.
[12] Aljohani S, Alshomrani M. P285: Comparison of two nucleic acid amplification assays, the probetec et assay and xpert mtb/rif assay, for detection of mycobacterium tuberculosis in respiratory specimens. Antimicrob Resist Infect Control 2013;2:P285. doi:10.1186/2047-2994-2-s1-p285.
[13] Raizada N, Sachdeva KS, Chauhan DS, Malhotra B, Reddy K, Dave P V., et al. A Multi-site validation in India of the line probe assay for the rapid diagnosis of multi-drug resistant tuberculosis directly from sputum specimens. PLoS One 2014;9. doi:10.1371/journal.pone.0088626.
[14] Al-Darraji HAA, Razak HA, Ng KP, Altice FL, Kamarulzaman A. The Diagnostic Performance of a Single GeneXpert MTB/RIF Assay in an Intensified Tuberculosis Case Finding Survey among HIV-Infected Prisoners in Malaysia. PLoS One 2013. doi:10.1371/journal.pone.0073717.
[15] Mashinji V, Maghimbi A, Loy G, Mwakyusa S, Majigo M. 162 Challenges Fueling the Complexities of TB Diagnosis & TBHIV Comorbidity in Tanzania- IHV experience. JAIDS J Acquir Immune Defic Syndr 2014. doi:10.1097/01.qai.0000446746.99602.a8.
[16] Ikuabe PO, Ebuenyi ID. Prevalence of rifampicin resistance by automated Genexpert rifampicin assay in patients with pulmonary tuberculosis in Yenagoa, Nigeria. Pan Afr Med J 2018. doi:10.11604/pamj.2018.29.204.14579.
[17] Evans CA. Genexpert-a game-changer for tuberculosis control? PLoS Med 2011;8. doi:10.1371/journal.pmed.1001064.
[18] Singh UB, Pandey P, Mehta G, Bhatnagar AK, Mohan A, Goyal V, et al. Genotypic, phenotypic and clinical validation of genexpert in extra-pulmonary and pulmonary tuberculosis in India. PLoS One 2016;11. doi:10.1371/journal.pone.0149258.
[19] Pandey P, Pant ND, Rijal KR, Shrestha B, Kattel S, Banjara MR, et al. Diagnostic Accuracy of GeneXpert MTB/RIF assay in comparison to conventional drug susceptibility testing method for the diagnosis of multidrug-resistant tuberculosis. PLoS One 2017;12. doi:10.1371/journal.pone.0169798.
[20] Pandey S, Congdon J, McInnes B, Pop A, Coulter C. Evaluation of the GeneXpert MTB/RIF assay on extrapulmonary and respiratory samples other than sputum: a low burden country experience. Pathology 2017;49:70–4. doi:10.1016/j.pathol.2016.10.004.
[21] Drobniewski F, Cooke M, Jordan J, Casali N, Mugwagwa T, Broda A, et al. Systematic review, meta-analysis and economic modelling of molecular diagnostic tests for antibiotic resistance in tuberculosis. Health Technol Assess (Rockv) 2015;19:1–188. doi:10.3310/hta19340.
[22] Minion J, Pai M. Bacteriophage assays for rifampicin resistance detection in Mycobacterium tuberculosis: Updated meta-analysis. Int J Tuberc Lung Dis 2010;14:941–51.
[23] A. F, F.S. M, J. O, T. F-J, F. G, O. S. Performance comparison of lowenstein-jensen (LJ) media supplemented with pyruvate, glycerol and a combination of both to assess the growth of mycobacterium tuberculosis complex. Am J Respir Crit Care Med 2017;195. doi:10.1164/ajrccm-conference.2017.A61.
[24] Drobniewski F, Cooke M, Jordan J, Casali N, Mugwagwa T, Broda A, et al. Systematic review, meta-analysis and economic modelling of molecular diagnostic tests for antibiotic resistance in tuberculosis. Health Technol Assess (Rockv) 2015;19:1–188. doi:10.3310/hta19340.
[25] Luetkemeyer AF, Kendall MA, Wu X, Lourenço MC, Jentsch U, Swindells S, et al. Evaluation of two line probe assays for rapid detection of mycobacterium tuberculosis, tuberculosis (TB) drug resistance, and non-TB mycobacteria in HIV-infected individuals with suspected TB. J Clin Microbiol 2014;52:1052–9. doi:10.1128/JCM.02639-13.
[26] Singh BK, Sharma SK, Sharma R, Sreenivas V, Myneedu VP, Kohli M, et al. Diagnostic utility of a line probe assay for multidrug resistant-TB in smear-negative pulmonary tuberculosis. PLoS One 2017;12. doi:10.1371/journal.pone.0182988.
[27] Lin HC, Perng CL, Lai YW, Lin FG, Chiang CJ, Lin HA, et al. Molecular screening of multidrug-resistance tuberculosis by a designated public health laboratory in Taiwan. Eur J Clin Microbiol Infect Dis 2017;36:2431–9. doi:10.1007/s10096-017-3082-9.
[28] Theron G, Peter J, Richardson M, Warren R, Dheda K, Steingart KR. GenoType® MTBDRsl assay for resistance to second-line anti-tuberculosis drugs. Cochrane Database Syst Rev 2016;2016. doi:10.1002/14651858.CD010705.pub3.
[29] Pang Y, Dong H, Tan Y, Deng Y, Cai X, Jing H, et al. Rapid diagnosis of MDR and XDR tuberculosis with the MeltPro TB assay in China. Sci Rep 2016;6. doi:10.1038/srep25330.
[30] Malbruny B, Le Marrec G, Courageux K, Leclercq R, Cattoir V. Rapid and efficient detection of Mycobacterium tuberculosis in respiratory and non-respiratory samples. Int J Tuberc Lung Dis 2011;15:553–5. doi:10.5588/ijtld.10.0497.
[31] Ritu S, Jyoti A, Prabha L, Manpreet B, Myneeedu BP, Digamber B. Comparison of line probe assay with liquid culture for rapid detection of multi-drug resistance in Mycobacterium tuberculosis. Indian J Med Res 2012;136:1044–7.
[32] Tomasicchio M, Theron G, Pietersen E, Streicher E, Stanley-Josephs D, Van Helden P, et al. The diagnostic accuracy of the MTBDRplus and MTBDRsl assays for drug-resistant TB detection when performed on sputum and culture isolates. Sci Rep 2016;6. doi:10.1038/srep17850.
[33] Albert H, Bwanga F, Mukkada S, Nyesiga B, Ademun JP, Lukyamuzi G, et al. Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda. BMC Infect Dis 2010;10. doi:10.1186/1471-2334-10-41.
[34] Rufai SB, Kumar P, Singh A, Prajapati S, Balooni V, Singh S. Comparison of xpert MTB/RIF with line probe assay for detection of rifampin-monoresistant mycobacterium tuberculosis. J Clin Microbiol 2014;52:1846–52. doi:10.1128/JCM.03005-13.
[35] Yadav RN, Singh BK, Sharma SK, Sharma R, Soneja M, Sreenivas V, et al. Comparative Evaluation of GenoType MTBDRplus Line Probe Assay with Solid Culture Method in Early Diagnosis of Multidrug Resistant Tuberculosis (MDR-TB) at a Tertiary Care Centre in India. PLoS One 2013;8. doi:10.1371/journal.pone.0072036.
[36] Jain A, Singh PK, Chooramani G, Dixit P, Malhotra HS. Drug resistance and associated genetic mutations among patients with suspected MDR-TB in Uttar Pradesh, India. Int J Tuberc Lung Dis 2016;20:870–5. doi:10.5588/ijtld.15.0874.
[37] Liu Z, Pan A, Wu BB, Zhou L, He H, Meng Q, et al. Feasibility of a new model for early detection of patients with multidrug-resistant tuberculosis in a developed setting of eastern China. Trop Med Int Heal 2017;22:1328–33. doi:10.1111/tmi.12934.
[38] Mironova S, Kontsevaya I, Pimkina E, Nikolayevskyy V, Skenders G, Kummik T, et al. Performance of the GenoType® MTBDRplus assay for detection of Mycobacterium tuberculosis drug resistance in routine settings: A multicentre study. Clin Microbiol Infect 2011;17:S588.
[39] Gersh J, Matemo D, Kinuthia J, Feldman Z, Dawson J, LaCourse S, et al. Evaluation of novel screens for pulmonary TB in people living with HIV in Kenya. Am J Respir Crit Care Med Conf Am Thorac Soc Int Conf ATS 2018;197.
[40] Davis JL, Ho C, Cattamanchi A, Grinsdale J, Metcalfe JZ, Pandori M, et al. The Clinical And Public Health Impact Of Automated Nucleic Acid Testing For TB Evaluation In San Francisco, 2011, p. A5314–A5314. doi:10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a5314.